Jim Fink

Jim Fink is chief investment strategist for Jim Fink's Options for Income and Velocity Trader. He has traded options for more than 20 years and generated personal profits of more than $5 million. Jim also serves as an investment analyst at Investing Daily’s flagship investing publication, Personal Finance.

Hopelessly overeducated, Jim holds a bachelor's degree from Yale University, a master's degree from Harvard's Kennedy School of Government, a law degree from Columbia University, and an MBA from the University of Virginia's Darden School of Business. For good measure, he has been a member of the Illinois and D.C. bars.

Prior to joining Investing Daily, and when not incurring student loans hiding out in academe, Jim practiced telecommunications regulatory law for nine years until he realized that he made more money trading stock options than writing briefs. After attending business school, Jim switched gears to the investment realm full-time, working for a university endowment, a private wealth management firm, an insurance and financial planning company, and as a Senior Analyst for an online investment newsletter service that encourages the wearing of funny hats.

A possible but unlikely descendant of legendary brawler and boatman Mike Fink, Jim defies his heritage, believing that investing success requires patience and analysis, not swashbuckling bravado. Besides his passion for analyzing and writing about stocks, Jim likes to hike in the desert Southwest, vacation in Las Vegas, play tennis, and feed his toddler son Cheerios.

Analyst Articles

In the current issue of Roadrunner Stocks, two new BUY recommendations and two SELL recommendations have been issued. 1. The Value Portfolio is adding discount shoe retailer DSW Inc. (DSW) and selling cellulose manufacturer Rayonier Advanced Materials (RYAM).2. The Momentum Portfolio is adding heart-pump manufacturer Abiomed… Read More

Rayonier Advanced Materials (Nasdaq: RYAM) is in trouble with Eastman Chemical, its largest customer that represents 31% of total sales (page F-12). On August 18th, Rayonier filed a Form 8-K disclosing a contractual dispute with Eastman as to whether Rayonier must lower the contract price it charges Eastman… Read More

In the current issue of Roadrunner Stocks, two new BUY recommendations and two SELL recommendations have been issued. 1. The Value Portfolio is adding female medical-device manufacturer Utah Medical Products (UTMD) and selling computer network equipment manufacturer Brocade Communications (BRCD).2. The Momentum Portfolio is adding video… Read More